Search for: "King v. Dole"
Results 1 - 20
of 38
Sorted by Relevance
|
Sort by Date
5 Mar 2015, 6:52 am
"Chevron or Dole in King v Burwell? [read post]
7 Mar 2015, 10:15 am
Defenders of the administration’s position in King v. [read post]
7 Dec 2014, 9:01 pm
In Part One of this two-part series, I contended that the reading of the Obamacare statute offered by the plaintiffs in the important King v. [read post]
2 Mar 2015, 6:42 am
Burwell, Halbig v. [read post]
7 Nov 2014, 9:48 am
Obamacare’s opponents have depicted the challenges in King v. [read post]
5 Mar 2015, 11:10 am
In in South [Dakota] v. [read post]
9 Mar 2015, 4:04 pm
Dole (1987) and NFIB v. [read post]
12 Nov 2014, 8:17 am
Tuesday afternoon I had the pleasure of debating/discussing King v. [read post]
4 Jun 2013, 8:46 am
After delivering a fiery dissent from Monday morning’s decision in Maryland v. [read post]
10 Mar 2015, 9:01 pm
During last week’s oral argument in King v. [read post]
26 Mar 2012, 11:06 am
In Gerner v. [read post]
6 Sep 2011, 1:39 pm
., the next Stephen King or John Grisham -- but are rather dedicated almost exclusively to literary fiction. [read post]
20 Mar 2012, 11:13 am
King & Spalding, 467 U.S. 69 (1984). [read post]
21 Jan 2010, 4:25 pm
The Cost of Complex Litigation: Preliminary Rhetoric for the Motion to Dismiss – from class action attorney Andrew Trask of McGuireWoods on his blog, Class Action Countermeasures A Trap for the Unwary: "Professional" Duties and the Professional Exemption – from New York employment attorney Joseph Dole of Bond, Schoeneck & King on the firm’s New York Labor & Employment Law Report [read post]
8 Oct 2009, 9:12 am
Case 08-17166The court will also hear Doe v. [read post]
18 Aug 2010, 12:19 am
King Pharmaceuticals, Inc. v. [read post]
12 Sep 2019, 1:02 pm
Carnival Cruise Lines, Case No. 19-cv-21725-KING (S.D. [read post]
25 Jan 2011, 10:58 pm
General GSK critiques Anti-Counterfeiting Trade Agreement (IP Watch) WHO Members show dismay at delay on Counterfeit Medicines Group (IP Watch) WHO R&D financing committee approved with controversial industry expert (IP Watch) (KEI) (KEI) (KEI) BioCentury this week explores orphan drugs with HP&M attorney and NORD Board Chair (FDA Law Blog) EU: Paediatric extensions and transitional provisions: a question of timing (The SPC Blog) India: Patent Office continue refusing pharmaceutical… [read post]
28 Jan 2009, 6:33 pm
People buying the spinach would not have known that any company but Dole was involved in the manufacturing process. [read post]
4 Feb 2009, 5:03 pm
People buying the spinach would not have known that any company but Dole was involved in the manufacturing process. [read post]
